(주)서울파마 / SEOUL pharma
SEOUL pharma's KOBDi Score is 40.19 as of Sep 2026, up 0.34 points since Apr 2025; it rose in 3 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 51% of companies in its industry, against 51% in Aug 2026 and 50% in Apr 2025. Its strongest position was 52% (Jul 2026) and its weakest 48% (Aug 2025).
A year earlier, in Aug 2025, its score was 39.94 and it was ahead of about 48% of companies in its industry.
| Sep 2026 | 40.19 | ahead of 51% |
| Aug 2026 | 40.19 | ahead of 51% |
| Jul 2026 | 40.19 | ahead of 52% |
| Jun 2026 | 40.19 | ahead of 52% |
| May 2026 | 40.19 | ahead of 52% |
| Apr 2026 | 40.19 | ahead of 52% |
| Mar 2026 | 40.19 | ahead of 52% |
| Feb 2026 | 40.10 | ahead of 52% |
| Dec 2025 | 39.94 | ahead of 52% |
| Aug 2025 | 39.94 | ahead of 48% |
| Jul 2025 | 39.84 | ahead of 50% |
| May 2025 | 39.84 | ahead of 51% |
| Apr 2025 | 39.84 | ahead of 50% |
Where is SEOUL pharma located?
SEOUL pharma is registered at 서울특별시 서초구 언남9길, South Korea (postal code 06777).
What industry is SEOUL pharma in?
SEOUL pharma belongs to Wholesale & Retail Trade › Wholesale – Household Goods & Appliances › Pharmaceutical wholesaler.
How many employees does SEOUL pharma have?
SEOUL pharma has 1–4 employees.
What is SEOUL pharma's KOBDi Score?
40.19 as of September 2026, ahead of about 51% of companies in its industry.
Who are SEOUL pharma's competitors?
Similar companies include 뜰, Mediforum and 팜에드.

